(Fighting against New Coronary Pneumonia) Global war epidemic: Canada approves first clinical trial of new coronavirus vaccine
China News Service, Toronto, May 16 (Reporter Yu Ruidong) Canadian Prime Minister Justin Trudeau announced in Ottawa on May 16 local time that Health Canada has approved the country ’s first clinical trial of a new coronavirus vaccine.
The Canadian Vaccine Center at Dalhousie University in Halifax will conduct this clinical trial. Trudeau also said that the Canadian National Research Council will work with vaccine manufacturers, and once the vaccine clinical trials are successful, Canada can produce vaccines domestically.
Data Map: Canadian Prime Minister Trudeau. China News Service issued MSC / Kuhlmann photo
He said that vaccine research and development will take time, but this is "encouraging news."
Health Canada has confirmed to many mainstream media that it is the vaccine developed by the Chinese biological company CanSinoBIO that is approved for clinical trials. The department stated that the test application met the necessary requirements for safety and quality.
The National Research Council of Canada announced on May 12 that it is cooperating with Kangxinuo Biology in Tianjin, China to promote the development of a new coronavirus vaccine.
The vaccine was named Ad5-nCoV. As one of the few vaccines against neocoronavirus in the world, it has entered the second phase of human clinical trials in China in mid-April and at the same time in the world.
The head of the Canadian Vaccine Center told the Canadian Broadcasting Corporation that it hopes that relevant clinical trials can begin within the next two weeks. The clinical trial will be conducted in three phases, and the participating population will gradually expand.
During the epidemic, two passengers wearing masks rested in the deserted Toronto Pearson International Airport. China News Service reporter Yu Ruidong
The National Research Council of Canada said recently that it is working with many trusted partners in Canada and internationally to find a response to the new crown epidemic. For example, in addition to working with Chinese partners, Canada is also collaborating with Massachusetts-based VBI Vaccine to develop pan-coronavirus vaccines against New Coronavirus, SARS virus, and Middle East Respiratory Syndrome (MERS) virus.
After the outbreak of New Coronary Pneumonia, the Canadian government increased its funding for medical research, including about 1.1 billion Canadian dollars for medical research and vaccine development of New Coronavirus. The Canadian National Research Council is also collaborating with relevant institutions at the University of Saskatchewan to advance the development of new coronavirus antigens in mammalian cells. Recently, the Canadian Ministry of Health approved the first new coronavirus serum antibody detection technology.
As of the evening of May 16, the cumulative number of confirmed and suspected cases in Canada was 75,864, 37,819 were recovered, and 5,679 related deaths. (Finish)